WEST PHARMACEUTICAL SERVICES, INC. Current Liabilities
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Current Liabilities of $640.50 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-07-23
- 2026-06-30: Liabilities, Current $640.50M.
- 2026-03-31: Liabilities, Current $674.00M.
- 2025-12-31: Liabilities, Current $654.90M.
- 2025-09-30: Liabilities, Current $635.40M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $640.50M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $674.00M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $654.90M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $635.40M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $604.60M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $526.70M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $550.40M 10-K · filed 2026-02-17 |
| 2024-09-30 | $516.50M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $633.70M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $648.40M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $671.80M 10-K · filed 2025-02-18 |
| 2023-09-30 | $533.50M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $511.60M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $534.90M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $519.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | $456.70M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $565.10M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $584.80M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $594.10M 10-K · filed 2023-02-21 |
| 2021-09-30 | $558.60M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $472.60M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $482.80M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $503.40M 10-K · filed 2022-02-22 |
| 2020-09-30 | $447.70M 10-Q · filed 2020-10-23 |
| 2020-06-30 | $375.20M 10-Q · filed 2020-07-24 |
| 2020-03-31 | $344.40M 10-Q · filed 2020-04-24 |
| 2019-12-31 | $341.60M 10-K · filed 2021-02-23 |
| 2019-09-30 | $335.00M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $313.20M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $301.10M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $283.70M 10-K · filed 2020-02-24 |
| 2018-09-30 | $288.80M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $287.60M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $263.40M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $279.50M 10-K · filed 2019-02-28 |
| 2017-09-30 | $300.00M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $289.00M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $256.50M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $241.00M 10-K · filed 2018-02-26 |
| 2016-09-30 | $236.80M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $239.40M 10-Q · filed 2016-08-01 |
| 2016-03-31 | $241.10M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $314.30M 10-K · filed 2017-02-28 |
| 2015-09-30 | $299.90M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $313.70M 10-Q · filed 2015-08-03 |
| 2015-03-31 | $296.60M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $252.50M 10-K · filed 2016-02-26 |
| 2014-09-30 | $242.50M 10-Q · filed 2014-11-03 |
| 2014-06-30 | $221.20M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $227.60M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $236.90M 10-K · filed 2015-02-25 |
| 2013-09-30 | $246.80M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $218.70M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $208.10M 10-Q · filed 2013-05-06 |
| 2012-12-31 | $261.80M 10-K · filed 2014-02-27 |
| 2012-09-30 | $275.60M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $320.20M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $302.40M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $243.20M 10-K · filed 2013-02-27 |
| 2011-09-30 | $229.30M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $192.70M 10-Q/A · filed 2011-08-08 |
| 2011-03-31 | $182.80M 10-Q · filed 2011-05-05 |
| 2010-12-31 | $169.70M 10-K/A · filed 2012-03-01 |
| 2010-09-30 | $158.20M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $158.60M 10-Q · filed 2010-08-05 |
| 2009-12-31 | $171.10M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |